Skip to main content
Erschienen in: BMC Infectious Diseases 1/2024

Open Access 01.12.2024 | Matters Arising

Letter to the editor regarding the case report: unregulated medication use and complications: is self-medication a common problem with anti-tuberculous therapy (ATT)? Role for patient education

verfasst von: Vijay Alexander, Jasper Rathinam J., John Titus George, Jackwin Sam Paul

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2024

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
Editor’s note: The Editors invited a response from the Authors of the published article to which this Matters Arising refers. At the time of publication, the Authors had not replied to correspondence from the journal.
ARTICLE TYPE: Matters Arising (In correspondence to https://​doi.​org/​10.​1186/​s12879-023-08637-7).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
To the Editor,
We read with great interest the case report titled ‘unregulated medication use and complications: a case study of prolonged self-treated tuberculosis in Nepal’ [1]. The authors describe a middle-aged gentleman diagnosed with tuberculosis once, later continues to self-medicate for years without seeking medical attention.
The case in discussion is unusual for many reasons, and raises multiple questions relevant to the management of tuberculosis. While poor adherence to the prescribed course of anti-tuberculous therapy and defaulting treatment are commonly reported, self-medication and prolonged intake over and above the prescribed duration is extremely uncommon [2]. Studies have assessed multiple interventions such as direct observed therapy administered by trained health workers, SMS combined with education, drug reminder box and reinforced counselling method to improve medication adherence to ATT [3]. Since the problem identified is poor adherence, these interventions target those that require ATT. Most health programmes do not have long follow up care of patients cured of TB. As stated above, most studies do not report self-treatment with ATT as a problem among TB patients beyond prescribed course of treatment.
Over the counter medication use and self-medication is a common problem in low- and middle-income countries where there are few safety checks in place to limit the dispensing of medications without prescription. Commonly bought medications include antipyretics, antibiotics, analgesics, and steroids [4]. However, over-medication with ATT is rare and has not been previously reported in literature. Common reasons for self-medication of various drugs include urgency of the situation, financial constraints, previous experience, advice obtained from paramedics and pharmacists, easy availability of drugs, non-availability of medical insurance to make a visit to the clinic, lack of time and poor access to a health care facility [5].
This case highlights the importance of patient education in tuberculosis, especially regarding the duration of therapy, documentation of sputum conversion and microbiological cure and, possible long-term sequelae of tuberculosis infection. A brief note on the patient’s perspective would have been extremely beneficial and would have helped the authors and the readers understand his concerns and thought process behind treating himself with ATT for years together. We can only speculate the reasons why this patient resorted to prolonged period of self-medication with ATT. It is possible that he was not cognizant of the fact that tuberculosis is curable with a finite course of appropriate ATT. He may also have been unaware of sequelae of past tuberculosis such as bronchiectasis and lung fibrosis. The stigma of living with tuberculosis may also have been a motivating factor to take treatment plan into his own hands without involving family or healthcare professionals.
This lays the foundation for healthcare system research, with a crucial focus on identifying the tipping point within the system. Employing a mixed-methods approach, we can quantify the myriad challenges patients encounter after receiving ATT but also gain insights into the factors that either support or hinder their access to proper follow-up care. This would entail an initial qualitative data collection through in-depth interviews and focus group discussions (FGDs) to delve into the reasons for non-adherence to anti-tuberculous treatment done in the exploratory phase. Following this, a quantitative phase should be performed by designing a cross-sectional study based on identified qualitative themes, aiming to quantify specific factors related to non-adherence. Subsequent research would triangulate by aligning qualitative and quantitative findings to reveal convergent or divergent patterns. These insights will not only inform public health system improvements but also assist clinicians in crafting more appropriate management and patient education strategies.

Acknowledgements

Not applicable

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Achhami E, Lamichhane S, Mahaju S, Kandel A, Poudel A, Kc R. Unregulated medication use and complications: a case study of prolonged self-treated tuberculosis in Nepal. BMC Infect Dis. 2023;23(1):659.CrossRefPubMedPubMedCentral Achhami E, Lamichhane S, Mahaju S, Kandel A, Poudel A, Kc R. Unregulated medication use and complications: a case study of prolonged self-treated tuberculosis in Nepal. BMC Infect Dis. 2023;23(1):659.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Pradipta IS, Houtsma D, van Boven JFM, Alffenaar JWC, Hak E. Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies. NPJ Prim Care Respir Med. 2020;30(1):21.CrossRefPubMedPubMedCentral Pradipta IS, Houtsma D, van Boven JFM, Alffenaar JWC, Hak E. Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies. NPJ Prim Care Respir Med. 2020;30(1):21.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Sazali MF, Rahim SSSA, Mohammad AH, Kadir F, Payus AO, Avoi R, et al. Improving tuberculosis medication adherence: the potential of integrating digital technology and health belief model. Tuberc Respir Dis (Seoul). 2023;86(2):82–93.CrossRefPubMed Sazali MF, Rahim SSSA, Mohammad AH, Kadir F, Payus AO, Avoi R, et al. Improving tuberculosis medication adherence: the potential of integrating digital technology and health belief model. Tuberc Respir Dis (Seoul). 2023;86(2):82–93.CrossRefPubMed
4.
Zurück zum Zitat Narang P, Garg V, Sharma A. Regulatory, safety and economic considerations of over-the-counter medicines in the Indian population. Discov Health Syst. 2023;2(1):17.CrossRefPubMedPubMedCentral Narang P, Garg V, Sharma A. Regulatory, safety and economic considerations of over-the-counter medicines in the Indian population. Discov Health Syst. 2023;2(1):17.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Rathod P, Sharma S, Ukey U, Sonpimpale B, Ughade S, Narlawar U et al. Prevalence, pattern, and reasons for Self-Medication: a community-based cross-sectional study from Central India. Cureus 15(1):e33917. Rathod P, Sharma S, Ukey U, Sonpimpale B, Ughade S, Narlawar U et al. Prevalence, pattern, and reasons for Self-Medication: a community-based cross-sectional study from Central India. Cureus 15(1):e33917.
Metadaten
Titel
Letter to the editor regarding the case report: unregulated medication use and complications: is self-medication a common problem with anti-tuberculous therapy (ATT)? Role for patient education
verfasst von
Vijay Alexander
Jasper Rathinam J.
John Titus George
Jackwin Sam Paul
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2024
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09170-x

Weitere Artikel der Ausgabe 1/2024

BMC Infectious Diseases 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.